跳转至内容
Merck
CN

32142

Supelco

Pirbuterol acetate

VETRANAL®, analytical standard

登录查看公司和协议定价

别名:
(RS)-2-(tert-Butylamino)-1-(6-hydroxymethyl-5-hydroxy-2-pyridyl)ethanol acetate salt, 6-(2-tert-Butylamino-1-hydroxyethyl)-2-hydroxymethylpyridin-3-ol acetate
经验公式(希尔记法):
C12H20N2O3 · C2H4O2
CAS号:
分子量:
300.35
Beilstein:
13318829
EC 号:
MDL编号:
UNSPSC代码:
41116107
PubChem化学物质编号:
NACRES:
NA.24

等级

analytical standard

质量水平

产品线

VETRANAL®

技术

HPLC: suitable
gas chromatography (GC): suitable

应用

forensics and toxicology
pharmaceutical (small molecule)
veterinary

格式

neat

InChI

1S/C12H20N2O3.C2H4O2/c1-12(2,3)13-6-11(17)8-4-5-10(16)9(7-15)14-8;1-2(3)4/h4-5,11,13,15-17H,6-7H2,1-3H3;1H3,(H,3,4)

InChI key

QSXMZJGGEWYVCN-UHFFFAOYSA-N

基因信息

human ... ADRB2(154)

正在寻找类似产品? 访问 产品对比指南

相关类别

应用

Refer to the product′s Certificate of Analysis for more information on a suitable instrument technique. Contact Technical Service for further support.

推荐产品

Find a digital Reference Material for this product available on our online platform ChemisTwin® for NMR. You can use this digital equivalent on ChemisTwin® for your sample identity confirmation and compound quantification (with digital external standard). An NMR spectrum of this substance can be viewed and an online comparison against your sample can be performed with a few mouseclicks. Learn more here and start your free trial.

法律信息

VETRANAL is a registered trademark of Merck KGaA, Darmstadt, Germany

WGK

WGK 3


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Paradoxical asthma hazard of short-acting beta2-agonists.
M J Seed et al.
Allergy, 63(2), 241-241 (2007-11-22)
D Solé et al.
Revista paulista de medicina, 111(3), 397-402 (1993-05-01)
To determine the maximal bronchodilator dose of procaterol and pirbuterol administered by inhalation with an without an aerochamber (Aerocâmera) to children with acute bronchial asthma attacks. Prospective. 18 children (6-15 years of age) with acute bronchial asthma attacks (FEV1 <
Life-threatening asthma during treatment with salmeterol.
Miles Weinberger et al.
The New England journal of medicine, 355(8), 852-853 (2006-08-25)
The use of two inhaled beta agonists for the treatment of COPD: a summary of European data.
K Holten et al.
The Journal of asthma : official journal of the Association for the Care of Asthma, 30(2), 123-126 (1993-01-01)
J S Kelloway et al.
Managed care interface, 10(9), 99-107 (1997-08-05)
Managed care plans evaluate therapeutic alternatives to identify the most cost-effective medications for asthma. Three hundred one patients with asthma were randomized to receive the beta-agonist pirbuterol from either a manually operated metered dose inhaler (MDI) or a breath-actuated inhaler

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门